Article: New Gleevec(R) Data: Prolonged Efficacy with Approved 400 mg Daily Dose and Potential for Improved Response at Higher Dose.

Article: REVLIMID(TM) Clinical Data in Newly Diagnosed ...
PR Newswire;  December 7, 2004 ;     700+ words ... ... approach for patients with newly diagnosed multiple myeloma ... initial therapy for newly diagnosed MM. The median age ... in the treatment of newly diagnosed MM," explained Dr ... orally at a dose of 25 mg daily on days 1-21 of a ...

Article: REVLIMID(R) Clinical Results as Oral Treatment Regimen in ...
PR Newswire;  December 13, 2005 ;     700+ words ... ... on the treatment of newly diagnosed multiple myeloma patients ... initial therapy for newly diagnosed MM. The median age ... and dexamethasone in newly diagnosed MM, such as the large ... orally at a dose of 25 mg daily on days 1-21 of a ...

Article: Gleevec is superior to traditional drug therapy for patients ...
Cancer Weekly;  April 8, 2003 ;     700+ words ... ... option for patients with newly diagnosed Philadelphia chromosome ... nearly 3-quarters of newly diagnosed patients in the chronic ... taken orally at 400 mg daily, with IFN/Ara ... recruited, 74% of newly diagnosed patients treated with ...

Article: Gleevec is superior to traditional drug therapy for patients ...
Biotech Week;  April 9, 2003 ;     700+ words ... ... option for patients with newly diagnosed Philadelphia chromosome ... nearly 3-quarters of newly diagnosed patients in the chronic ... taken orally at 400 mg daily, with IFN/Ara ... recruited, 74% of newly diagnosed patients treated with ...

Article: Data Published in New England Journal of Medicine Show ...
PR Newswire;  March 12, 2003 ;     700+ words ... ... option for patients with newly diagnosed Philadelphia chromosome ... three- quarters of newly diagnosed patients in the chronic ... taken orally at 400 mg daily, with IFN/Ara ... recruited, 74% of newly diagnosed patients treated with ...

Article: In a New Study Actonel(R) 35 mg Once-a-Week Was as Effective as 5 ...
PR Newswire;  November 12, 2001 ;     700+ words ... ... comparable to the 4.0 percent increase achieved with the 5 mg daily dose. Total hip, femoral neck and trochanteric BMD also increased ... profile of risedronate 35 mg once a week was comparable to the 5 mg daily dose. The study included postmenopausal women at least 50 ...

Article: Efficacy and acceptability of risedronate 5 mg ...
Climacteric;  April 1, 2006 ;     700+ words ...Key words: RISEDRONATE, DAILY OR WEEKLY REGIMEN, BONE RESORPTION, C-TERMINAL TELOPEPTIDE TYPE I COLLAGEN ABSTRACT Objective Risedronate is a bisphosphonate used in the treatment of osteoporosis. It has a strong effect in inhibiting osteoclast activity. The primary objective of this study was to